vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

BLACKBERRY Ltd is the larger business by last-quarter revenue ($141.8M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). BLACKBERRY Ltd runs the higher net margin — 9.7% vs 3.3%, a 6.3% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -0.8%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $7.6M). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs 5.6%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

BB vs NATR — Head-to-Head

Bigger by revenue
BB
BB
1.1× larger
BB
$141.8M
$123.8M
NATR
Growing faster (revenue YoY)
NATR
NATR
+5.6% gap
NATR
4.7%
-0.8%
BB
Higher net margin
BB
BB
6.3% more per $
BB
9.7%
3.3%
NATR
More free cash flow
BB
BB
$9.8M more FCF
BB
$17.4M
$7.6M
NATR
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
5.6%
NATR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
NATR
NATR
Revenue
$141.8M
$123.8M
Net Profit
$13.7M
$4.1M
Gross Margin
77.5%
72.5%
Operating Margin
8.4%
4.3%
Net Margin
9.7%
3.3%
Revenue YoY
-0.8%
4.7%
Net Profit YoY
224.5%
1379.4%
EPS (diluted)
$0.02
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
NATR
NATR
Q4 25
$141.8M
$123.8M
Q3 25
$129.6M
$128.3M
Q2 25
$121.7M
$114.8M
Q1 25
$141.7M
$113.2M
Q4 24
$143.6M
$118.2M
Q3 24
$126.2M
$114.6M
Q2 24
$123.4M
$110.6M
Q1 24
$102.1M
$111.0M
Net Profit
BB
BB
NATR
NATR
Q4 25
$13.7M
$4.1M
Q3 25
$13.3M
$5.3M
Q2 25
$1.9M
$5.3M
Q1 25
$-7.4M
$4.7M
Q4 24
$-10.5M
$-321.0K
Q3 24
$-19.7M
$4.3M
Q2 24
$-41.4M
$1.3M
Q1 24
$-56.2M
$2.3M
Gross Margin
BB
BB
NATR
NATR
Q4 25
77.5%
72.5%
Q3 25
74.5%
73.3%
Q2 25
74.2%
71.7%
Q1 25
73.5%
72.1%
Q4 24
78.1%
72.0%
Q3 24
70.2%
71.3%
Q2 24
72.9%
71.4%
Q1 24
71.2%
Operating Margin
BB
BB
NATR
NATR
Q4 25
8.4%
4.3%
Q3 25
8.9%
7.0%
Q2 25
1.6%
3.7%
Q1 25
-5.6%
5.4%
Q4 24
13.6%
3.8%
Q3 24
1.7%
4.6%
Q2 24
-10.5%
5.1%
Q1 24
50.0%
4.2%
Net Margin
BB
BB
NATR
NATR
Q4 25
9.7%
3.3%
Q3 25
10.3%
4.2%
Q2 25
1.6%
4.6%
Q1 25
-5.2%
4.2%
Q4 24
-7.3%
-0.3%
Q3 24
-15.6%
3.8%
Q2 24
-33.5%
1.2%
Q1 24
-55.0%
2.1%
EPS (diluted)
BB
BB
NATR
NATR
Q4 25
$0.02
$0.23
Q3 25
$0.02
$0.30
Q2 25
$0.00
$0.28
Q1 25
$-0.01
$0.25
Q4 24
$-0.02
$-0.02
Q3 24
$-0.03
$0.23
Q2 24
$-0.07
$0.07
Q1 24
$-0.08
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$304.2M
$93.9M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$161.6M
Total Assets
$1.2B
$261.1M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
NATR
NATR
Q4 25
$304.2M
$93.9M
Q3 25
$290.5M
$95.6M
Q2 25
$306.6M
$81.3M
Q1 25
$337.8M
$86.5M
Q4 24
$220.0M
$84.7M
Q3 24
$211.0M
$78.7M
Q2 24
$229.0M
$68.7M
Q1 24
$237.1M
$77.8M
Total Debt
BB
BB
NATR
NATR
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
$2.1M
Stockholders' Equity
BB
BB
NATR
NATR
Q4 25
$741.1M
$161.6M
Q3 25
$725.1M
$166.7M
Q2 25
$725.1M
$163.7M
Q1 25
$719.9M
$167.1M
Q4 24
$725.2M
$161.0M
Q3 24
$732.1M
$162.6M
Q2 24
$742.6M
$156.4M
Q1 24
$775.1M
$159.7M
Total Assets
BB
BB
NATR
NATR
Q4 25
$1.2B
$261.1M
Q3 25
$1.2B
$264.8M
Q2 25
$1.2B
$254.9M
Q1 25
$1.3B
$252.7M
Q4 24
$1.3B
$240.9M
Q3 24
$1.3B
$245.3M
Q2 24
$1.3B
$235.8M
Q1 24
$1.4B
$247.3M
Debt / Equity
BB
BB
NATR
NATR
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
NATR
NATR
Operating Cash FlowLast quarter
$18.3M
$9.9M
Free Cash FlowOCF − Capex
$17.4M
$7.6M
FCF MarginFCF / Revenue
12.3%
6.1%
Capex IntensityCapex / Revenue
0.6%
1.9%
Cash ConversionOCF / Net Profit
1.34×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
NATR
NATR
Q4 25
$18.3M
$9.9M
Q3 25
$3.9M
$18.5M
Q2 25
$-18.0M
$4.3M
Q1 25
$41.6M
$2.6M
Q4 24
$6.0M
$12.2M
Q3 24
$-16.0M
$9.6M
Q2 24
$-15.1M
$1.3M
Q1 24
$-15.5M
$2.2M
Free Cash Flow
BB
BB
NATR
NATR
Q4 25
$17.4M
$7.6M
Q3 25
$3.1M
$16.8M
Q2 25
$-18.9M
$3.0M
Q1 25
$41.2M
$1.5M
Q4 24
$5.2M
$10.0M
Q3 24
$-16.5M
$7.9M
Q2 24
$-16.5M
$-2.0M
Q1 24
$-17.6M
$-1.5M
FCF Margin
BB
BB
NATR
NATR
Q4 25
12.3%
6.1%
Q3 25
2.4%
13.1%
Q2 25
-15.5%
2.6%
Q1 25
29.1%
1.3%
Q4 24
3.6%
8.5%
Q3 24
-13.1%
6.9%
Q2 24
-13.4%
-1.9%
Q1 24
-17.2%
-1.4%
Capex Intensity
BB
BB
NATR
NATR
Q4 25
0.6%
1.9%
Q3 25
0.6%
1.3%
Q2 25
0.7%
1.2%
Q1 25
0.3%
1.0%
Q4 24
0.6%
1.9%
Q3 24
0.4%
1.5%
Q2 24
1.1%
3.0%
Q1 24
2.1%
3.3%
Cash Conversion
BB
BB
NATR
NATR
Q4 25
1.34×
2.41×
Q3 25
0.29×
3.46×
Q2 25
-9.47×
0.81×
Q1 25
0.55×
Q4 24
Q3 24
2.21×
Q2 24
0.97×
Q1 24
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons